Six-month follow-up of gut microbiota richness in patients with COVID-19

Yanfei Chen, Silan Gu, Yunbo Chen, Haifeng Lu, Ding Shi, Jing Guo, Wen-Rui Wu, Ya Yang, Yongtao Li, Kai-Jin Xu, Cheng Ding, Rui Luo, Chenjie Huang, Ling Yu, Min Xu, Ping Yi, Jun Liu, Jing-Jing Tao, Hua Zhang, Longxian Lv, Baohong Wang, Jifang Sheng, Lanjuan Li, Yanfei Chen, Silan Gu, Yunbo Chen, Haifeng Lu, Ding Shi, Jing Guo, Wen-Rui Wu, Ya Yang, Yongtao Li, Kai-Jin Xu, Cheng Ding, Rui Luo, Chenjie Huang, Ling Yu, Min Xu, Ping Yi, Jun Liu, Jing-Jing Tao, Hua Zhang, Longxian Lv, Baohong Wang, Jifang Sheng, Lanjuan Li

No abstract available

Keywords: COVID-19; intestinal microbiology.

Conflict of interest statement

Competing interests: None declared.

Figures

Figure 1
Figure 1
Changes of faecal microbial communities in different stages (acute, convalescence, postconvalescence) of patients with COVID-19 (n=30), compared with uninfected controls (n=30). (A) α-Diversity, illustrated by microbiota richness (Chao 1 index), was reduced in COVID-19 (p

References

    1. Yeoh YK, Zuo T, GC-Y L. Gut microbiota composition reflects disease severity and dysfunctional immune responses in patients with COVID-19. Gut 2021;70:698–706.
    1. Huang C, Huang L, Wang Y, et al. . 6-Month consequences of COVID-19 in patients discharged from Hospital: a cohort study. Lancet 2021;397:220–32. 10.1016/S0140-6736(20)32656-8
    1. Nabavi N. Long covid: how to define it and how to manage it. BMJ 2020;370:m3489. 10.1136/bmj.m3489
    1. Gu S, Chen Y, Wu Z. Alterations of the gut microbiota in patients with COVID-19 or H1N1 influenza. Clin Infect Dis 2020.
    1. Lahti L, Salojärvi J, Salonen A, et al. . Tipping elements in the human intestinal ecosystem. Nat Commun 2014;5:4344. 10.1038/ncomms5344
    1. Buffie CG, Pamer EG. Microbiota-mediated colonization resistance against intestinal pathogens. Nat Rev Immunol 2013;13:790–801. 10.1038/nri3535
    1. Finlay BB, Amato KR, Azad M, et al. . The hygiene hypothesis, the COVID pandemic, and consequences for the human microbiome. Proc Natl Acad Sci U S A 2021;118. 10.1073/pnas.2010217118
    1. Sonnweber T, Sahanic S, Pizzini A, et al. . Cardiopulmonary recovery after COVID-19 - an observational prospective multi-center trial. Eur Respir J 2020. 10.1183/13993003.03481-2020. [Epub ahead of print: 10 Dec 2020].
    1. Dickson RP, Singer BH, Newstead MW, et al. . Enrichment of the lung microbiome with gut bacteria in sepsis and the acute respiratory distress syndrome. Nat Microbiol 2016;1:16113. 10.1038/nmicrobiol.2016.113
    1. Zhang Q, Ran X, He Y, et al. . Acetate downregulates the activation of NLRP3 inflammasomes and attenuates lung injury in neonatal mice with bronchopulmonary dysplasia. Front Pediatr 2020;8:595157. 10.3389/fped.2020.595157

Source: PubMed

Patrocinadores y Colaboradores

Condiciones médicas

Intervenciones de drogas

3
Suscribir